Companies
SA
STOXX 600Health Care· Germany
SRES
Status-Quo-PlayerSartorius Stedim Biotech
$188.70
+3.57%
Open $180.50·Prev $182.20
as of 17 Apr
STATUS-QUO-PLAYER
Power Core
The Power Core is regulatory validation lock-in: once a biologic drug is approved on a Sartorius Stedim consumable specification, switching that consumable out triggers a regulatory change control filing with re-validation risk.
Published20 Apr 2026
UniverseSTOXX 600
SectorHealth Care
↑
Direction of Movement
lateral
ROC 200
-11.2%
SRES
Sartorius Stedim Biotech
$188.70
+3.57%
Open $180.50·Prev $182.20
as of 17 Apr
↓Overvalued by 607%
DCF Fair Value: $26.67
News
No recent news available.
mOS zones are proprietary L17X overlays and do not constitute trading signals or investment advice.